Infliximab treatment reduces depressive symptoms in patients with ankylosing spondylitis: an ancillary study to a randomized controlled trial (ASSERT)

Infliximab treatment reduces depressive symptoms in patients with ankylosing spondylitis: an ancillary study to a randomized controlled trial (ASSERT)

Abstract Background Patients with ankylosing spondylitis (AS) are at increased risk of depression. This increased risk has been hypothesized to be solely secondary due to AS-related symptoms, or additionally due to a common inflammatory pathway. From a clinical perspective, it is important to know w...

Full description

Bibliographic Details
Main Authors: Casper Webers, Carmen Stolwijk, Olga Schiepers, Thea Schoonbrood, Astrid van Tubergen, Robert Landewé, Désirée van der Heijde, Annelies Boonen
Format: Article
Language:English
Published: BMC 2020-09-01
Series:Arthritis Research & Therapy
Subjects:
Ankylosing spondylitis
Depressive symptoms
Anti-TNF-α therapy
Randomized controlled trial
Online Access:http://link.springer.com/article/10.1186/s13075-020-02305-w

Internet

http://link.springer.com/article/10.1186/s13075-020-02305-w

Similar Items